Stemline Therapeutics Announces New England Journal of Medicine Publication of ELZONRIS (tagraxofusp) Pivotal Study Results

NEXT STORY
Report from the Annual General Meeting of Immunicum AB (publ) on April 25, 2019
PREV STORY
Mateon and Oncotelic Complete Their Merger and Create a New Immuno-Oncology Company with a Late-Stage Clinical Asset Against Cancer and a Promising Product Pipeline
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Ebola Vaccine Regimen from Johnson & Johnson and Bavarian Nordic Supports World Health Organization in Efforts to Prevent Spread of Ebola in West Africa

author_avatar
NASDAQ Market News

Merus to Participate in a Fireside Chat at the 2021 RBC Capital Markets Global Healthcare Conference

author_avatar
NASDAQ Market News

ORIC Pharmaceuticals Provides Corporate Update and Highlights Key 2021 Milestones

author_avatar
NASDAQ Market News